Literature DB >> 15446797

Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy.

Tomas Kron1, Grigor Grigorov, Edward Yu, Slav Yartsev, Jeff Z Chen, Eugene Wong, George Rodrigues, Kris Trenka, Terry Coad, Glenn Bauman, Jake Van Dyk.   

Abstract

Lung cancer treatment is one of the most challenging fields in radiotherapy. The aim of the present study was to investigate what role helical tomotherapy (HT), a novel approach to the delivery of highly conformal dose distributions using intensity-modulated radiation fan beams, can play in difficult cases with large target volumes typical for many of these patients. Tomotherapy plans were developed for 15 patients with stage III inoperable non-small-cell lung cancer. While not necessarily clinically indicated, elective nodal irradiation was included for all cases to create the most challenging scenarios with large target volumes. A 2 cm margin was used around the gross tumour volume (GTV) to generate primary planning target volume (PTV2) and 1 cm margin around elective nodes for secondary planning target volume (PTV1) resulting in PTV1 volumes larger than 1000 cm3 in 13 of the 15 patients. Tomotherapy plans were created using an inverse treatment planning system (TomoTherapy Inc.) based on superposition/convolution dose calculation for a fan beam thickness of 25 mm and a pitch factor between 0.3 and 0.8. For comparison, plans were created using an intensity-modulated radiation therapy (IMRT) approach planned on a commercial treatment planning system (TheraplanPlus, Nucletron). Tomotherapy delivery times for the large target volumes were estimated to be between 4 and 19 min. Using a prescribed dose of 60 Gy to PTV2 and 46 Gy to PTV1, the mean lung dose was 23.8+/-4.6 Gy. A 'dose quality factor' was introduced to correlate the plan outcome with patient specific parameters. A good correlation was found between the quality of the HT plans and the IMRT plans with HT being slightly better in most cases. The overlap between lung and PTV was found to be a good indicator of plan quality for HT. The mean lung dose was found to increase by approximately 0.9 Gy per percent overlap volume. Helical tomotherapy planning resulted in highly conformal dose distributions. It allowed easy achievement of two different dose levels in the target simultaneously. As the overlap between PTV and lung volume is a major predictor of mean lung dose, future work will be directed to control of margins. Work is underway to investigate the possibility of breath-hold techniques for tomotherapy delivery to facilitate this aim.

Entities:  

Mesh:

Year:  2004        PMID: 15446797     DOI: 10.1088/0031-9155/49/16/014

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  13 in total

1.  Skin dose study of chest wall treatment with tomotherapy.

Authors:  Khosrow Javedan; Geoffrey Zhang; Richard Mueller; Eleanor Harris; Lawrence Berk; Kenneth Forster
Journal:  Jpn J Radiol       Date:  2009-11-27       Impact factor: 2.374

Review 2.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

3.  Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis.

Authors:  C Song; H Pyo; J Kim; Y K Lim; W C Kim; H J Kim; D W Kim; K H Cho
Journal:  Strahlenther Onkol       Date:  2012-08-17       Impact factor: 3.621

4.  Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.

Authors:  P Mavroidis; C Shi; G A Plataniotis; M G Delichas; B Costa Ferreira; S Rodriguez; B K Lind; N Papanikolaou
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

5.  Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.

Authors:  Ivan S Vogelius; David C Westerly; George M Cannon; Thomas R Mackie; Minesh P Mehta; Chikao Sugie; Søren M Bentzen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-07       Impact factor: 7.038

6.  Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions.

Authors:  Florian Sterzing; Thomas Welzel; Gabriele Sroka-Perez; Kai Schubert; Jürgen Debus; Klaus K Herfarth
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

7.  Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.

Authors:  Jeong-Seon Ji; Chi-Wha Han; Jeong-Won Jang; Bo-In Lee; Byung-Wook Kim; Hwang Choi; Ji-Yoon Kim; Young-Nam Kang; Chul-Seung Kay; Ihl-Bohng Choi
Journal:  Radiat Oncol       Date:  2010-06-28       Impact factor: 3.481

8.  Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal.

Authors:  Tomas Kron; David Eyles; L John Schreiner; Jerry Battista
Journal:  J Med Phys       Date:  2006-10

9.  Tomotherapy as a tool in image-guided radiation therapy (IGRT): current clinical experience and outcomes.

Authors:  S Yartsev; T Kron; J Van Dyk
Journal:  Biomed Imaging Interv J       Date:  2007-01-01

10.  Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy.

Authors:  Youngkyong Kim; Seong Eon Hong; Moonkyoo Kong; Jinhyun Choi
Journal:  Cancer Res Treat       Date:  2013-12-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.